Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

JOHNSON & JOHNSON (JNJ)
Mes dernières consult.
Most popular
Report
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Johnson & Johnson : 35 years later, Tylenol deaths still unsolved

share with twitter share with LinkedIn share with facebook
share via e-mail
0
10/05/2017 | 12:55pm CET

In 1982, cyanide-laced Tylenol capsules killed seven people in the Chicago area, sparking one of the first massive recalls in the United States and revolutionizing packaging for over-the-counter medications sold in the country. But the case has never been solved.

The deaths began on Sept. 29, when 12-year-old Mary Kellerman died within hours of taken a capsule of Extra-Strength Tylenol. Later that same day, a postal worker, Adam Janus died. Both had been poisoned with potassium cyanide, which investigators later determined had been put inside the capsules of Tylenol.

Another five people would die, including Adam Janus' brother, Stanley Janus and sister-in-law Theresa Janus, who had taken capsules from the same bottle of Tylenol that killed the postal worker. Mary McFarland, Paula Prince and Mary Reiner, all living in or near Chicago, also died. Tylenol samples taken from each of the victims' homes tested positive for cyanide.

The results of the test prompted one of the first massive recalls in U.S. history. Thirty-five years ago today, on Oct. 5, 1982, Johnson & Johnson, the maker of Tylenol, pulled millions of dollars worth of product off store shelves, reducing the company's earnings by $50 million. There was nationwide panic as worried consumers went to hospitals out of fear of poisoning. The Food and Drug Administration counted hundreds of copycat incidents nationwide, including one in 1986 in which two people in died after taking cyanide-laced Excedrin capsules.

Investigators believe someone pulled packages of the capsules off the shelf, opened up the capsules and replaced the drug inside with cyanide before putting the packages back on the shelf. The ease with which capsules can be contaminated prompted drugmakers to move away from capsules and instead produce solid caplets. Companies also began implementing the use of tamper-resistant packaging for the drugs.

Despite the far-reaching impact of the case, the FBI never solved the question of who was responsible for the tampering.

The only person convicted in relation to the case was James Lewis, who sent a letter to Johnson & Johnson demanding $1 million in order to "stop the killings." He spent 12 years in prison for extortion, but police never charged him with tampering with the capsules.

In 2011, the FBI investigated the possibility so-called "Unabomber" Theodore Kaczynski, who grew up in the Chicago area, may have been behind the killings.

The Chicago Daily Herald said the FBI handed over the case to the Arlington Heights, Ill., Police Department. Deputy Chief Mike Hernandez told the newspaper the department is concerned too much time has passed in order to solve the crime.

"We're concerned about how long it's been. It's been a concern of the task force, as more time goes by," he said.

Years after the initial deaths, advances in technology allowed investigators to potential DNA evidence and a fingerprint smudge on one of the Tylenol bottles. But neither resulted in any arrests.

Though investigators on the case no longer regularly meet, the Daily Herald said, Hernandez said there's still hope.

"But this case is still a high priority. It's not gathering dust," he said.

Copyright 2017 United Press International, Inc. (UPI). Any reproduction, republication, redistribution and/or modification of any UPI content is expressly prohibited without UPI's prior written consent., source US Top News

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on JOHNSON & JOHNSON
12/15 JOHNSON & JOHNSON : ordered to pay $15M in vaginal mesh case
12/15 CONSUMERS ENERGY : Newsweek Ranks Consumers Energy as #1 Company in Michigan in ..
12/15 JOHNSON & JOHNSON : Jury awards $15 million in j&j trial
12/15 JOHNSON & JOHNSON : Janssen and Leading Advocacy Organizations Introduce Cancer...
12/14 JOHNSON & JOHNSON : Los Alamos research fundamental to first efficacy study for ..
12/14 JOHNSON & JOHNSON : Innovation Announces Launch of JLABS @ Shanghai in Collabora..
12/14 JOHNSON & JOHNSON : Bergen jury gets pelvic mesh case
12/14 JOHNSON & JOHNSON : and 4mm Navigational Bi-Directional Ablation catheters
12/14 JOHNSON & JOHNSON : J&Js Darzalex shows promise in newly-diagnosed multiple myel..
12/14 JOHNSON & JOHNSON : J&J`s Darzalex cuts risk of disease progression and death by..
More news
News from SeekingAlpha
02:01p DOMINION ENERGY : Recent Dividend Increase For The Conservative Income Investor
09:00a RETIREMENT STRATEGY : Yes, You Can Retire With Less Than You Think
12/16 AUTOMATIC DATA PROCESSING : Great Total Return And Recent Dividend Hike For Inco..
12/15 Just Turned 40? How To Reach A Goal Of $1.5 Million.
12/15 MY JOURNEY TO FINANCIAL INDEPENDENCE : 86-Stock November Portfolio Update - Buyi..
Financials ($)
Sales 2017 76 324 M
EBIT 2017 23 523 M
Net income 2017 16 391 M
Debt 2017 17 115 M
Yield 2017 2,35%
P/E ratio 2017 23,89
P/E ratio 2018 19,64
EV / Sales 2017 5,24x
EV / Sales 2018 4,83x
Capitalization 383 B
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 23
Average target price 146 $
Spread / Average Target 2,8%
EPS Revisions
Managers
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Dominic J. Caruso Chief Financial Officer & Vice President
Paulus Stoffels Chief Scientific Officer & Executive VP
Charles O. Prince Independent Director
William David Perez Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON23.65%382 722
PFIZER14.53%221 738
NOVARTIS13.09%221 731
ROCHE HOLDING LTD.4.94%212 270
MERCK AND COMPANY-4.47%153 386
AMGEN20.99%128 515